Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

NCT06997367 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis (TB)

Interventions

BIOLOGICAL: MTBVAC
BIOLOGICAL: BCG Sii

Sponsor

Bharat Biotech International Limited